These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 3497285

  • 21. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K, Toge T, Yanagawa E, Hamada Y, Seto Y, Yamada H, Toi M, Hattori T.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [Abstract] [Full Text] [Related]

  • 22. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M, Yasumoto K, Harada M, Matsuzaki G, Ishida T, Sugimachi K, Nomoto K.
    Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
    [Abstract] [Full Text] [Related]

  • 23. Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients.
    Boyer PJ, Berek JS, Zighelboim J.
    Obstet Gynecol; 1989 May; 73(5 Pt 1):793-7. PubMed ID: 2784847
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of cytotoxicity to autologous tumor cells by the regional lymph node cells of patients with primary lung cancer.
    Kadoyama C, Kimura H, Yamaguchi Y.
    Jpn J Clin Oncol; 1987 Mar; 17(1):29-39. PubMed ID: 2951535
    [Abstract] [Full Text] [Related]

  • 26. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
    Brooks B, Rees RC.
    Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
    [Abstract] [Full Text] [Related]

  • 27. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients.
    Nakamura H, Ishiguro K, Mori T.
    Cancer; 1988 Dec 15; 62(12):2489-97. PubMed ID: 3142676
    [Abstract] [Full Text] [Related]

  • 28. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
    Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY.
    Cancer Res; 1995 Nov 01; 55(21):4988-94. PubMed ID: 7585540
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL.
    Cancer Res; 1993 Oct 15; 53(20):4745-9. PubMed ID: 8402652
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Adoptive immunotherapy by intra-arterial infusion of ATLAK or Allo-TLAK cells in patients with head and neck cancer].
    Ikawa T, Eura M, Fukiage T, Murakami H, Yamasaki S, Fukuda K, Fukushima M, Arishima S, Maehara T, Ishikawa T.
    Gan To Kagaku Ryoho; 1989 Apr 15; 16(4 Pt 2-2):1438-47. PubMed ID: 2786378
    [Abstract] [Full Text] [Related]

  • 33. [Induction of LAK cells and CTL in patients with brain tumor and research of its clinical application].
    Moriki A.
    Nihon Geka Hokan; 1989 Jan 01; 58(1):107-18. PubMed ID: 2802908
    [Abstract] [Full Text] [Related]

  • 34. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
    Blanchard DK, Kavanagh JJ, Sinkovics JG, Cavanagh D, Hewitt SM, Djeu JY.
    Cancer Res; 1988 Nov 15; 48(22):6321-7. PubMed ID: 2972357
    [Abstract] [Full Text] [Related]

  • 35. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M.
    Clin Cancer Res; 1998 Mar 15; 4(3):713-20. PubMed ID: 9533541
    [Abstract] [Full Text] [Related]

  • 36. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antitumor activity of regional lymph node lymphocytes in patients with lung cancer.
    Yaita H, Yasumoto K, Nagashima A, Sugimachi K, Nomoto K.
    J Surg Oncol; 1988 Jul 01; 38(3):165-72. PubMed ID: 3260643
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.